The absolute density of neurotransmitter receptors in the brain. Example for dopamine receptors
- PMID: 3039256
- DOI: 10.1016/0160-5402(87)90048-9
The absolute density of neurotransmitter receptors in the brain. Example for dopamine receptors
Abstract
Since the absolute density of dopamine receptors can vary in disease, it is essential to establish the normal values for the absolute densities of D1 and D2 receptors in the brain. Absolute densities are most conveniently reported in units of picomoles per gram of original tissue, readily permitting their comparison to data obtained by positron emission tomography in patients. The density of D1 receptors is approximately 120 pmol/g in the rat striatum and 19 pmol/g in the human striatum. The density of D2 receptors is about 32 pmol/g in the rat striatum and 14 pmol/g in the human striatum, these values being determined by Teflon-glass homogenization and the centrifugation method. The customary Polytron-homogenization procedure results in a loss of about 9% of the D2 receptors in rat tissue and about 28% in human tissues; filtration results in a further loss of about 12%. There is general agreement between the in vitro and in vivo densities, but only if the receptors are measured by the amount of radioisotope specifically displaced.
Similar articles
-
Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's, and Huntington's diseases.Neuropsychopharmacology. 1987 Dec;1(1):5-15. doi: 10.1016/0893-133x(87)90004-2. Neuropsychopharmacology. 1987. PMID: 2908095
-
Dopamine D1 and D2 receptors in spontaneously hypertensive rat brain striatum.Can J Physiol Pharmacol. 1989 Dec;67(12):1596-7. doi: 10.1139/y89-256. Can J Physiol Pharmacol. 1989. PMID: 2697462
-
Autoradiographic localization of dopamine D1 and D2 receptors in rat nucleus accumbens: resistance to differential rearing conditions.Neuroscience. 1991;45(2):281-90. doi: 10.1016/0306-4522(91)90226-e. Neuroscience. 1991. PMID: 1762680
-
Neurotransmitter receptor mapping by autoradiography and other methods.Annu Rev Neurosci. 1986;9:27-59. doi: 10.1146/annurev.ne.09.030186.000331. Annu Rev Neurosci. 1986. PMID: 2423006 Review. No abstract available.
-
Dopamine receptors in Parkinson's disease.Prog Neuropsychopharmacol Biol Psychiatry. 1988;12(2-3):173-82. doi: 10.1016/0278-5846(88)90035-8. Prog Neuropsychopharmacol Biol Psychiatry. 1988. PMID: 3290993 Review.
Cited by
-
Imaging of dopamine D2 and somatostatin receptors in vivo using single-photon emission tomography in a patient with a TSH/PRL-producing pituitary macroadenoma.Eur J Nucl Med. 1993 Jun;20(6):555-61. doi: 10.1007/BF00175168. Eur J Nucl Med. 1993. PMID: 8339737
-
Brain neuroreceptor density and personality traits: towards dimensional biomarkers for psychiatric disorders.Philos Trans R Soc Lond B Biol Sci. 2018 Apr 19;373(1744):20170156. doi: 10.1098/rstb.2017.0156. Philos Trans R Soc Lond B Biol Sci. 2018. PMID: 29483342 Free PMC article. Review.
-
Evaluation of SCH 39166 as PET ligand for central D1 dopamine receptor binding and occupancy in man.Psychopharmacology (Berl). 1995 Oct;121(3):300-8. doi: 10.1007/BF02246067. Psychopharmacology (Berl). 1995. PMID: 8584610 Clinical Trial.
-
PET measurement of D2 and S2 receptor binding of 3-N-[( 2'-18F]fluoroethyl)spiperone in baboon brain.Eur J Nucl Med. 1988;14(2):80-7. doi: 10.1007/BF00253446. Eur J Nucl Med. 1988. PMID: 2968911
-
NCQ 298, a new selective iodinated salicylamide ligand for the labelling of dopamine D2 receptors.Psychopharmacology (Berl). 1991;103(1):6-18. doi: 10.1007/BF02244067. Psychopharmacology (Berl). 1991. PMID: 1672460
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources